Gilead Sciences
GILD
#129
Rank
ยฃ112.90 B
Marketcap
ยฃ90.99
Share price
-1.14%
Change (1 day)
27.14%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ5.51 Billion

According to Gilead Sciences's latest financial reports the company has ยฃ5.51 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ9.21 B61.67%
2023-12-31ยฃ5.70 B8.03%
2022-12-31ยฃ5.27 B9.27%
2021-12-31ยฃ4.83 B-11.12%
2020-12-31ยฃ5.43 B-70.73%
2019-12-31ยฃ18.57 B-21.66%
2018-12-31ยฃ23.70 B25.58%
2017-12-31ยฃ18.87 B95.8%
2016-12-31ยฃ9.64 B-2.2%
2015-12-31ยฃ9.85 B51.52%
2014-12-31ยฃ6.50 B403.3%
2013-12-31ยฃ1.29 B12.18%
2012-12-31ยฃ1.15 B-81.91%
2011-12-31ยฃ6.36 B368.53%
2010-12-31ยฃ1.35 B32.77%
2009-12-31ยฃ1.02 B-16.16%
2008-12-31ยฃ1.22 B107.03%
2007-12-31ยฃ0.58 B23.34%
2006-12-31ยฃ0.47 B-64.31%
2005-12-31ยฃ1.34 B105.16%
2004-12-31ยฃ0.65 B65.27%
2003-12-31ยฃ0.39 B-32.75%
2002-12-31ยฃ0.58 B46.2%
2001-12-31ยฃ0.40 B16.98%
2000-12-31ยฃ0.34 B88.61%
1999-12-31ยฃ0.18 B199.66%
1998-12-31ยฃ60.8 M212.12%
1997-12-31ยฃ19.48 M-74.73%
1996-12-31ยฃ77.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
ยฃ7.08 B 28.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ4.71 B-14.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ4.25 B-22.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.95 B-82.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ2.97 B-46.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.24 B 103.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ13.93 B 152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ7.44 B 34.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ13.67 B 147.84%๐Ÿ‡บ๐Ÿ‡ธ USA